This page is no longer updated.
It was archived on 8 July 2008 and is kept for historical purposes only. The latest content is available at http://www.who.int/selection_medicines/en/

WHO/UNICEF
Technical Briefing Seminar
 
on Essential Medicines Policies

   

Venue: WHO Headquarters, Geneva, M-505

Dates: 8-12 October 2007
 

 

Key readings

Programme

PPT Presentations

TBS home

 

Previous seminars


Application form


Contacts


Participants


Briefing report

Monday 8 October 2007
Facilitation: Dr Richard Laing, PSM/PAR
 
Registration

08.30-09.00

M-505, M-Building, WHO/Headquarters  
Introduction
  09.00-09.30 Welcome - Objectives of the Seminar 
Dr Hans Hogerzeil, Director PSM
 
 
  09.30-10.15 Introduction of participants: Gallery of experts 
Dr Richard Laing, PSM/PAR and Dr Shanthi Pal, QSM
 
   
  10.15-10.45 Coffee    
  10.45-11.00 Seminar overview and administration
Mrs Helen Tata
Mrs Ann Wilberforce
 
   
  11.00-12.00 PSM and TCM roles and responsibilities in implementing the WHO Medicines Strategy     
    Dr Hans Hogerzeil, Director PSM

PSM Strategic Direction 2006-2007

 
   

Background documentation:

WHO Medicines Strategy: 2004-2007
Countries at the core
 

   
  12.00-12.30 Information resources

Mr Claude Da Re, Mrs Kath Hurst, Mrs Christine Encrenaz and Mrs Daniela Bagozzi, Mr Jrg Hetzke, Mr Thiago Miranda
 

   
  12.30-14.00 Lunch    
National Drug Policies  
 

14.00-14.30

National Medicines Policies 
Dr Richard Laing, PSM/PAR
 

Background documentation:

How to develop and implement a national drug policy
 

 National Medicines Policies

 
 

14.30-15.30

Indicators on pharmaceutical situations
Dr Daisy Carandang, TCM/MPM
 

Background documentation:

Fact book on WHO Level I & II Monitoring Indicators -- Households Survey document
 

Pharmaceutical monitoring and evaluation

 
 

15.30-15.45

Tea    
Selection of Essential Medicines  
  15.45-17.15 Update 2006 WHO Model List of Essential Medicines Selection, and Paediatric Medicines
Dr Suzanne Hill, PSM/PAR

 

Background documentation:

The Selection and Use of Essential Medicines
 

Selection of essential medicines

 
  17.30-19.00 Reception (Classic Cocktail) with PSM & TCM staff members
(WHO Restaurant, Main Building)
 
   
Tuesday 9 October 2007
Facilitation: Dr Sabine Kopp, PSM/QSM
 

Top of page

What is quality?  
  09.00-10.45 Medicines - Quality Control and Assurance
WHO normative functions in the field of pharmaceuticals
 
 
   
    Dr Lembit Rago

Medicines - Quality Control and Quality Assurance
 

 
    Dr Sabine Kopp, PSM/QSM

Drug regulation and quality assurance
 

 
   

Background documentation:

Effective medicines regulations
 

   
  10.45-11-00 Coffee    
  11-00-12.30 Medicines - Quality Control and Assurance (continued)    
  12.30-14.00 Lunch    
Prequalification  
14.00-15.45 Prequalification of essential medicines 
Dr Lembit Rago, Dr Raul Kiivet and Dr Andre Van Zyl, PSM/QSM


Background documentation:

Prequalifying Priority Medicines
 

Prequalification of Essential Medicines

15.45-16.00 Tea
16.00-17.00 Quality Control Assurance for Blood Products and Related Biologicals
Dr Ana Padilla, PSM/QSD

 

WHO Norms and Standards: Blood Products & related Biologicals

Evening Dinner, Geneva (Optional: all have to pay for themselves: sorry!)
Wednesday 10 October 2007
Facilitation: Dr Clive Ondari, PSM/PAR
 

Top of page

What is access?
09.00-10.30 Panel presentation and discussion
Access framework, HIV/AIDS, TB and Malaria
Dr Richard Laing

Access to Essential Medicines
 

Dr Vincent Habiyambere (HTM/HIV)

AMDS Contribution to the Technical Briefing Seminar

Ms Silvia Schwarte (GMP/SCM)

Access to Medicines: Antimalarials

Mr Robert Matiru (GDF-TB)
 Ms Atieno Ojoo (UNICEF)

WHO/UNICEF Technical Briefing Seminar on Essential Medicines Policies

Ms Sophie Logez (GFATM)

 Mrs Helen Tata, TCM.

Tool to Assess Procurement and Supply Management systems of Essential Medicines

Short presentations + Panel discussion

Background documentation:

Equitable access to essential medicines
 

10.30-10.45 Coffee
10.45-11.30 Discussion
11.30-12.30 Essential Medicines as a Human Right
Dr Hans Hogerzeil, Director PSM

Background documentation:

Is access to essential medicines as part of the fulfilment of the right to health enforceable through the courts?

Essential medicines and human rights: what can they learn from each other?

Essential Drugs Monitor: Access to essential medicines as a human right
 

Access to essential medicines as part of the fulfilment of the Right to Health

12.30-14.00 Lunch

During lunch Dr Jorge Bermudez, Executive Secretary of UNITAID will present a lecture on UNITAID. This will be held in the Kofi A. Annan Conference Room, UNAIDS/WHO Building, and will be open to all WHO and Geneva based staff:

"A new innovative mechanism for scaling up access to medicines for HIV/TB and malaria"
 

Together to heal
(20 MB)

(PDF file)

Medicine prices and financing
14.00-15.15 Medicine prices, WHO/NGO Price Survey Methodology
Dr Richard Laing, PSM/PAR, Ms Alexandra Cameron, PSM/PAR, Dr Gilles Forte, TCM/DAP

Background documentation:
Medicine Prices - a new approach to Measurement & BMJ Editorial

Prices & availability of common medicines at six sites in India using a standard methodology

HAI Medicine Prices website
 

Medicines prices: measurement and findings in countries

15.15-15.30 Tea
15.30-17.00 Hot topic ideas:
Medicines promotion - Dr Richard Laing, PAR
 

Codes and regulations
(37 MB)

Ethical Criteria for Promotion of Medicines
 

Corruption & Good Governance for Medicines - Dr Guitelle Baghdadi-Sabeti, PAR
 

Good Governance for Medicines

Medicines Transparency Alliance (MeTA) - Dr Richard Laing and Alexandra Cameron, PAR
 

Towards a Medicines Transparency Alliance (MeTA)

Thursday 11 October 2007
Facilitation: Dr Gilles Forte and Mrs Helen Tata, TCM
 

Top of page

Technical collaboration with regions and countries
09.00-09.20 WHO TCM strategy for working with and in countries
Harmonization and regional initiatives
Mrs M. Matsoso, Director, TCM

Background documentation:
WHO Medicines Strategy 2004-2007
 

Working with Countries, Harmonisation and Regional Initiatives

  09.20-09.40 Strategy for working with countries
Regional and Subregional perspective and experiences
Dr K. Weerasuriya, RA/SEARO

 

Strategies for Working with Countries Regional and Sub-Regional Perspective and Experiences

 
  09.40-10.45 Medicines Procurement and Supply Management Issues in the African Region
Mrs Helen Tata, Mrs Magali Babaley (TCM), Mr Jol Adagadzu, Director, Food and Drugs, FMOH, Nigeria
 

Mapping and In-depth Assessment of Medicines Procurement and Supply Systems

Medicines Procurement and Supply Management Issues in Nigeria

 
  10.45-11.00 Coffee    
  11.00-11.40 Discussion on regional and country activities.    
  11.40-12.30 International Regulatory Cooperation for Herbal Medicines (IRCH)
Dr Ziaorui Zhang, TCM/TRM
 

Global review of the challenges in use of traditional medicine and WHO perspective
(20 MB)
(PDF)
 

 
  12.30-14.00

Lunch

   
Global issues  
  14.00-15.30 Intellectual property rights, trade agreements and access to medicines: WHO's mandate and strategy in the implementation of the TRIPS Agreement and the Doha Declaration
Dr German Velasquez, TCM

Background documentation:
Globalization, TRIPS and access to pharmaceuticals
 

   
  15.30-16.00 Tea    
  16.00-17.00

 

Medicines Regulation and Counterfeit Issues
Dr Valerio Reggi (TCM)

Background documentation:
Essential Drugs Monitor No. 21 pages 2 and 3, Combating Counterfeit Drugs: Declaration of Rome www.who.int/medicines
 

Impact: a WHO initiative to combat counterfeit medical products

Strengthening national drug regulatory capacity
 

 
Friday 12 October 2007
Facilitation: Dr Richard Laing, PSM/PAR
 

Top of page

Safety
09.00-10.00 Pharmacovigilance: New challenges for WHO
WHO Collaborating Centre, Uppsala PSM/QSM
Dr Ronald Meyboom, WHO Collaborating Centre, Uppsala, PSM/QSM

Background documentation:
Pharmacovigilance: ensuring the safe use of medicines.
Safety of Medicines in Public Health Programmes: pharmacovigilance an essential tool
 

Pharmacovigilance and the WHO Collaborating Centre for International Drug Monitoring in Uppsala

What is rational medicine use?
10.00-12.30 Promoting rational use of medicines
Dr Richard Laing, PSM/PAR

Background documentation:
Promoting rational use of medicines: core components and containing antimicrobial resistance
 

Rational use of drugs: an overview

  10.45-11.00 Coffee    
  12.30 Closure
Dr Hans V. Hogerzeil and Dr Kris Weerasuriya
 
   
  14.00 Additional time for sessions, individual appointments with TCM and PSM staff